<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>LDL cholesterol - Ziba Guru</title>
	<atom:link href="https://ziba.guru/tag/ldl-cholesterol/feed/" rel="self" type="application/rss+xml" />
	<link>https://ziba.guru</link>
	<description>your path to beautiful life</description>
	<lastBuildDate>Wed, 09 Apr 2025 17:58:16 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://ziba.guru/wp-content/uploads/2025/02/cropped-ziba-favico-32x32.png</url>
	<title>LDL cholesterol - Ziba Guru</title>
	<link>https://ziba.guru</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Konjac glucomannan emerges as dual-action metabolic modulator: Clinical trials reveal 12% glucose reduction in obese populations</title>
		<link>https://ziba.guru/2025/04/konjac-glucomannan-emerges-as-dual-action-metabolic-modulator-clinical-trials-reveal-12-glucose-reduction-in-obese-populations/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=konjac-glucomannan-emerges-as-dual-action-metabolic-modulator-clinical-trials-reveal-12-glucose-reduction-in-obese-populations</link>
					<comments>https://ziba.guru/2025/04/konjac-glucomannan-emerges-as-dual-action-metabolic-modulator-clinical-trials-reveal-12-glucose-reduction-in-obese-populations/#respond</comments>
		
		<dc:creator><![CDATA[Louis Phaigh]]></dc:creator>
		<pubDate>Wed, 09 Apr 2025 17:58:16 +0000</pubDate>
				<category><![CDATA[Metabolic Health]]></category>
		<category><![CDATA[Nutritional Science]]></category>
		<category><![CDATA[dietary fiber]]></category>
		<category><![CDATA[functional foods]]></category>
		<category><![CDATA[gut microbiota]]></category>
		<category><![CDATA[insulin sensitivity]]></category>
		<category><![CDATA[konjac glucomannan]]></category>
		<category><![CDATA[LDL cholesterol]]></category>
		<category><![CDATA[metabolic health]]></category>
		<category><![CDATA[obesity management]]></category>
		<category><![CDATA[prebiotics]]></category>
		<category><![CDATA[weight management]]></category>
		<guid isPermaLink="false">https://ziba.guru/2025/04/konjac-glucomannan-emerges-as-dual-action-metabolic-modulator-clinical-trials-reveal-12-glucose-reduction-in-obese-populations/</guid>

					<description><![CDATA[<p>New clinical studies demonstrate konjac glucomannan&#8217;s ability to lower LDL cholesterol and fasting glucose while enhancing gut microbiota diversity, offering a novel dietary strategy for metabolic health management. Recent clinical trials highlight konjac glucomannan&#8217;s dual impact on glucose regulation and lipid metabolism, positioning this dietary fiber as a key component in obesity-related metabolic disorder management.</p>
<p>The post <a href="https://ziba.guru/2025/04/konjac-glucomannan-emerges-as-dual-action-metabolic-modulator-clinical-trials-reveal-12-glucose-reduction-in-obese-populations/">Konjac glucomannan emerges as dual-action metabolic modulator: Clinical trials reveal 12% glucose reduction in obese populations</a> first appeared on <a href="https://ziba.guru">Ziba Guru</a>.</p>]]></description>
										<content:encoded><![CDATA[<p><strong>New clinical studies demonstrate konjac glucomannan&#8217;s ability to lower LDL cholesterol and fasting glucose while enhancing gut microbiota diversity, offering a novel dietary strategy for metabolic health management.</strong></p>
<p>Recent clinical trials highlight konjac glucomannan&#8217;s dual impact on glucose regulation and lipid metabolism, positioning this dietary fiber as a key component in obesity-related metabolic disorder management.</p>
<div>
<h3>The Science Behind Konjac Glucomannan&#8217;s Metabolic Effects</h3>
<p>A June 2024 randomized controlled trial published in the <q>Journal of Nutritional Science</q> demonstrated that 12 weeks of 4g/day KGM supplementation resulted in 8-12% reductions in LDL cholesterol and fasting glucose levels among obese participants. Dr. Elena Marquez, lead researcher at the Barcelona Metabolic Institute, stated in the study&#8217;s press release: <q>Our findings position KGM as the first dietary fiber showing clinically significant improvements in both glycemic control and lipid profile simultaneously.</q></p>
<h3>Gut Microbiota: The Hidden Mechanism</h3>
<p>Emerging data from the European Food Safety Authority&#8217;s (EFSA) May 2024 technical report reveals KGM increases <em>Bifidobacterium</em> abundance by 30%, correlating with improved insulin sensitivity metrics. This prebiotic effect was particularly pronounced when combined with probiotic strains like <em>Lactobacillus rhamnosus</em>, as noted in a <q>Nature Gut Microbes</q> meta-analysis of 23 clinical trials.</p>
<h3>Practical Integration Strategies</h3>
<p>The China Food News Q2 2024 production report highlights new extraction methods achieving 95% KGM purity, enabling precise dosing recommendations. Nutritionists now advise:</p>
<ul>
<li>3-4g taken 30 minutes before meals for satiety effects</li>
<li>Combination with vitamin C to enhance viscosity</li>
<li>Gradual dose escalation to minimize gastrointestinal adaptation symptoms</li>
</ul>
<h3>Regulatory Milestones and Commercial Impact</h3>
<p>Following EFSA&#8217;s May 2024 approval of cholesterol maintenance claims, EU markets saw 22 new KGM-enriched product launches in June alone. Grand View Research projects the global KGM market will reach $1.2 billion by 2030, driven by its dual use in functional foods and plant-based meat alternatives.</p>
<h3>Historical Context of Dietary Fibers in Metabolic Health</h3>
<p>The current KGM boom follows decades of evolving fiber research. Psyllium husk dominated the 1990s cholesterol management market after FDA approval in 1998, while beta-glucan from oats gained traction post-2008 EFSA claims. However, KGM&#8217;s unique combination of high viscosity (3x greater than guar gum) and fermentation resistance gives it distinct advantages. As noted in the <q>2024 Global Nutrition Report</q>, <q>No previous dietary fiber has demonstrated KGM&#8217;s simultaneous impact on multiple metabolic pathways while maintaining consumer tolerability.</q></p>
<h3>Technological and Cultural Convergence</h3>
<p>China&#8217;s 18% YoY production increase (China Food News 2024) stems from novel extraction techniques like enzymatic hydrolysis refinement. This technological leap coincides with shifting consumer perceptions &#8211; FMCG Gurus&#8217; 2024 survey shows 42% of US supplement users now recognize KGM, up from 28% in 2022. The convergence of traditional Asian dietary practices (where konjac has been consumed for 1,500 years) with modern precision nutrition approaches creates unique market dynamics that previous fiber trends lacked.</p>
</div><p>The post <a href="https://ziba.guru/2025/04/konjac-glucomannan-emerges-as-dual-action-metabolic-modulator-clinical-trials-reveal-12-glucose-reduction-in-obese-populations/">Konjac glucomannan emerges as dual-action metabolic modulator: Clinical trials reveal 12% glucose reduction in obese populations</a> first appeared on <a href="https://ziba.guru">Ziba Guru</a>.</p>]]></content:encoded>
					
					<wfw:commentRss>https://ziba.guru/2025/04/konjac-glucomannan-emerges-as-dual-action-metabolic-modulator-clinical-trials-reveal-12-glucose-reduction-in-obese-populations/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
